Evidence map›Paper›PMID 38509168›Full record

ArticleScientific reports2024

Development of a novel AAK1 inhibitor via Kinobeads-based screening.

Akari Yoshida, Satomi Ohtsuka, Fumiya Matsumoto, Tomoyuki Miyagawa, Rei Okino, Yumeya Ikeda, Natsume Tada, Akira Gotoh, Masaki Magari, Naoya Hatano and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Akari Yoshida *Applied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Satomi Ohtsuka *Applied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Fumiya MatsumotoDepartment of Science Education, Graduate School of Education, Okayama University, Okayama, 700-8530, Japan.
Tomoyuki MiyagawaDepartment of Science Education, Graduate School of Education, Okayama University, Okayama, 700-8530, Japan.
Rei OkinoDepartment of Science Education, Graduate School of Education, Okayama University, Okayama, 700-8530, Japan.
Yumeya IkedaApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Natsume TadaApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Akira GotohApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Masaki MagariApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Naoya HatanoApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Ryo MorishitaCellFree Sciences Co. Ltd, Matsuyama, 790-8577, Japan.
Ayano SatohOrganelle Systems Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan.
Yukinari SunatsukiGraduate School of Natural Science and Technology, Okayama University, Okayama, 700-8530, Japan.
Ulf J NilssonDepartment of Chemistry, Lund University, Box 124, 221 00, Lund, Sweden.
Teruhiko IshikawaDepartment of Science Education, Graduate School of Education, Okayama University, Okayama, 700-8530, Japan. teruhiko@cc.okayama-u.ac.jp.
Hiroshi TokumitsuApplied Cell Biology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, 700-8530, Japan. tokumit@okayama-u.ac.jp.
Okayama University · JPCellFree Sciences (Japan) · JPLund University · SEOkayama University of Science · JP

Funding

Japan Society for the Promotion of Science JP21H02429
6 · The paper itself

Abstract

A chemical proteomics approach using Ca

Indexed as

Protein Kinase InhibitorsProtein Serine-Threonine KinasesCalcium-Calmodulin-Dependent Protein Kinase KinaseHeLa CellsHumansPhosphorylationAAK1 protein, humanCalcium-Calmodulin-Dependent Protein Kinase KinaseProtein Kinase InhibitorsProtein Serine-Threonine Kinases

Identifiers

PMID38509168
PMCPMC10954696
OpenAlexW4392983984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.